Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,613 signal articles · 100 in last 24h · 155,521 total before filter · latest 2h ago
100last 24h
848last 7d
142● bullish (7d)
90● bearish (7d)
214publishers
AllMacro191Earnings105M&A124Regulatory20Product21Analyst19
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is RTX (RTX) Undervalued As Its $22.9 Billion Missile Contract Expands Backlog?
Simply Wall St.28d agobearish
Is RTX (RTX) Undervalued As Its $22.9 Billion Missile Contract Expands Backlog?

RTX (RTX) is back in focus after its Raytheon business received a US$22.9b, seven year contract from the U.S. military to ramp Tomahawk missile production from 60 to 1,000 units annually. RTX shares trade at US$212.08 after a strong run, with an 18.05% 90-day share price return and a 13.26% year-to-date share price return. The 1-year total shareholder return of 33.96% points to momentum that aligns with these recent contract wins and capacity expansions. Spot 92 nuclear energy infrastructure...

Has Joby Aviation (JOBY) Fallen Far Enough to Look Cheap?
Simply Wall St.28d agobearish
Has Joby Aviation (JOBY) Fallen Far Enough to Look Cheap?

Joby Aviation stock has given up more than half its value year to date, yet broad valuation checks still suggest the shares are not a clear bargain on current fundamentals. The stock is down 50.2% year to date, which puts the recent slide firmly in focus for anyone weighing fresh capital against an already weak price chart. Valuation can be supported if Joby Aviation converts its early stage electric air taxi vision into predictable revenue and cash flow. The key risk is that long...

Tesla (TSLA) Recalls 3 Million China EVs Over Door Handles, Driver Monitoring
Insider Monkey28d agobearish
Tesla (TSLA) Recalls 3 Million China EVs Over Door Handles, Driver Monitoring

On August 21, CNBC reported that according to notices published by Tesla and China’s State Administration for Market Regulation, Tesla, Inc. (NASDAQ:TSLA) is voluntarily recalling about 3 million vehicles in China over two separate issues: door handles that can fail to open after severe crashes and deficient driver “attention monitoring” systems. The door handle flaw […]

Intuit (INTU) Slid on TurboTax Segment’s Underperformance
Insider Monkey28d agobearish
Intuit (INTU) Slid on TurboTax Segment’s Underperformance

Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron Financials ETF”. A letter can be downloaded here. In the quarter ended June 30, 2026, Baron Financials ETF (the Fund) increased by 1.82%, underperforming both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). […]

General Motors (GM) Faces Safety Probe Over Engine Failures in Nearly 1 Million Vehicles
Insider Monkey28d agobearish
General Motors (GM) Faces Safety Probe Over Engine Failures in Nearly 1 Million Vehicles

On August 21, Reuters reported that the National Highway Traffic Safety Administration opened an engineering analysis covering 997,743 General Motors Company (NYSE:GM) pickups and SUVs equipped with the L87 V-8 engine. The probe spans model years 2021 through 2026 and includes the Cadillac Escalade, Chevrolet Silverado 1500, and GMC Yukon, some of GM’s most profitable […]

1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm
StockStory28d agobearish
1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Celsius Holdings (CELH) Stock May Be No Bargain After A 50% Fall And Rich Earnings
Simply Wall St.28d agobearish
Celsius Holdings (CELH) Stock May Be No Bargain After A 50% Fall And Rich Earnings

Celsius Holdings stock has seen a sharp three year decline in shareholder returns, yet the market still prices the company on the rich side compared with its fundamentals. For investors, the question is why a stock with this recent track record continues to screen expensive on broad valuation checks. Over the past three years, Celsius Holdings shares have delivered a total return that is down about 49.5%, which puts recent enthusiasm in a different light. Expectations that the company can...

Apple (AAPL) Cuts Over 200 Jobs Across Siri and Vision Pro Units
Insider Monkey28d agobearish
Apple (AAPL) Cuts Over 200 Jobs Across Siri and Vision Pro Units

On August 21, 2026, Bloomberg reported that Apple Inc. (NASDAQ:AAPL) is eliminating more than 200 positions across its Siri and Vision Pro teams as it redirects resources toward artificial intelligence and new hardware. Roughly 100 roles are being cut from the Vision Pro organization, including largely shutting down its gaming team and shrinking the unit […]

Intuit’s (INTU) Workforce Restructuring Highlights AI Platform Scalability
Insider Monkey28d agobearish
Intuit’s (INTU) Workforce Restructuring Highlights AI Platform Scalability

Rothschild & Co Asset Management, an investment management company, released its “LongRun Equity Strategy” second-quarter 2026 investor letter. The letter can be downloaded here. The fund focuses on acquiring high-quality franchises for the long term, focusing on companies with strong competitive positions and sustainable business models. The strategy increased 7.6% (in EUR, unhedged) in the […]

Investing.com28d agobearish
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast

Investing.com -- BioNTech SE (NASDAQ: BNTX) shares tumbled 10% in Friday, rapidly unwinding the gains the stock had accumulated during a sector-wide mRNA rally just days prior. The selloff was triggered by the company’s announcement that it has terminated a Phase 2 trial for its mRNA cancer vaccine in colorectal cancer due to futility—a stark reality check for investors hoping the mRNA oncology revolution would be a rising tide that lifts all boats. The timing of the setback could not be more vi